AzTrials
AzTrials

Tracheal Intubation in ChildrenNCT02189590

Assessment of the I-gel and Air-Q Supraglottic Airways as Conduits for Tracheal Intubation in Children

A study testing i-gel and air-Q in people with Tracheal Intubation in Children, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if there is a difference in time for successful fiberoptic guided tracheal intubation through the i-gel or air-Q supraglottic airway. Read more about this study

Who is it for?
Ages 1 month to 6 yearsHealthy volunteers can take part
Conditions the study is for
Tracheal Intubation in Children
What is being tested?
i-gel and air-Q
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteUnited States
Study dates
Jul 2014to Sep 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children undergoing general anesthesia requiring tracheal intubation
  • Age one month to six years

Who cannot join

  • ASA class IV, V
  • Children receiving emergent surgery
  • History or high suspicion of a difficult airway
  • Active upper respiratory tract infection

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Anne & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: A Randomized Comparison of the I-gel and Air-Q as Conduits for Fiberoptic-guided Tracheal Intubation in Children

The purpose of this study is to determine if there is a difference in time for successful fiberoptic guided tracheal intubation through the i-gel or air-Q supraglottic airway.

Read the detailed description

The goal of this randomized study is to evaluate the efficacy of the i-gel as a conduit for fiberoptic tracheal intubation when compared to the air-Q in children. Intubations will be performed by residents in training. The primary outcome is of time for successful tracheal intubation. The investigators hypothesize that residents will intubate the trachea faster when using the air-Q as compared to the i-gel. The ease of placement of the supraglottic airway device, fiberoptic grade of laryngeal view, time for device removal after intubation, and peri-operative complications will also be assessed.

Being tested
i-gel, air-Q
Keywords
supraglottic airway, children, fiberoptic guided tracheal intubation, air-Q, i-gel

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • i-gelDevice

    Patients randomized to this intervention will have the i-gel placed following induction of general anesthesia. Subsequent tracheal intubation will be performed using the device as a conduit for fiberoptic-guided intubation. Following successful tracheal intubation, the device will be removed.

  • air-QDevice

    Patients randomized to this intervention will have the air-Q placed following induction of general anesthesia. Subsequent tracheal intubation will be performed using the device as a conduit for fiberoptic-guided intubation. Following successful tracheal intubation, the device will be removed.

Study groups in NCT02189590
Study groupRoleWhat they receive
air-QExperimentalPatients will receive the air-Q with size based on manufacturer recommendations of body weight
Receives: Device: air-Q
i-gelExperimentalPatients will receive the i-gel with size based on manufacturer recommendations of body weight
Receives: Device: i-gel

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Successful Tracheal Intubation

    Time to successful tracheal intubation when using fiberoptic bronchoscopy to intubate through the i-gel or air-Q ILA. Three separate times will be measured by an independent observer: 1) Time to first glottic view: defined as the duration of time ending with the first view of the glottic opening. 2) Time to carinal view: defined as the duration of time ending with visualization of the carina. 3) Time to successful tracheal intubation: defined as the duration of time ending with the observation of a square wave end-tidal capnogram after successful tracheal intubation

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Secondary outcomes (8)
  1. Ease of Placement of Supraglottic Airway

    Ease of placement of supraglottic device ranging from 1 (easy) to 4 (difficult).

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  2. Number of Attempts to Place the Supraglottic Device

    Number of attempts will be limited to 3

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  3. Supraglottic Airway Leak Pressure

    The airway pressure at which an airway leak is observed after placement of the supraglottic airway

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  4. Fiberoptic Grade of Laryngeal View

    Fiberoptic Grade of Laryngeal View through either the air Q or i-gel will be graded using a previously published grading system

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  5. Airway Maneuvers

    The number and type of airway maneuvers performed during tracheal intubation will be recorded

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  6. Postoperative Complications

    Complications noted postoperatively relating to the airway, such as sore throat or hoarseness.

    Measured: Participants will be followed for the duration of anesthesia and 24 hours postoperatively

  7. Time to Placement of Supraglottic Airway

    Time to placement of supraglottic device will be measured.

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  8. Number of Attempts to Place the Tracheal Tube

    Number of attempts to place the tracheal tube via fiberoptic bronchoscopy through supraglottic device will be limited to 3

    Measured: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionSep 2014
  4. Study completionSep 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
96 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02189590
Sponsor's protocol ID
I-gel versus air-Q
Status last verified
Oct 2014
First submitted
9 Jul 2014
Last updated
24 Oct 2014
Results posted
No
Data monitoring committee
No

Publications

  • Timmermann A. Supraglottic airways in difficult airway management: successes, failures, use and misuse. Anaesthesia. 2011 Dec;66 Suppl 2:45-56. doi: 10.1111/j.1365-2044.2011.06934.x.

    PubMed 22074079
  • Sohn LE, Jagannathan N, Sequera-Ramos L, Sawardekar A, Schaldenbrand K, De Oliveira GS. A randomised comparison of free-handed vs air-Q assisted fibreoptic-guided tracheal intubation in children < 2 years of age. Anaesthesia. 2014 Jul;69(7):723-8. doi: 10.1111/anae.12667. Epub 2014 May 2.

    PubMed 24797607
  • Mathis MR, Haydar B, Taylor EL, Morris M, Malviya SV, Christensen RE, Ramachandran SK, Kheterpal S. Failure of the Laryngeal Mask Airway Unique and Classic in the pediatric surgical patient: a study of clinical predictors and outcomes. Anesthesiology. 2013 Dec;119(6):1284-95. doi: 10.1097/ALN.0000000000000015.

    PubMed 24126262
  • Abukawa Y, Hiroki K, Ozaki M. Initial experience of the i-gel supraglottic airway by the residents in pediatric patients. J Anesth. 2012 Jun;26(3):357-61. doi: 10.1007/s00540-011-1322-1. Epub 2012 Feb 7.

    PubMed 22310833
  • Foucher-Lezla A, Lehousse T, Monrigal JP, Granry JC, Beydon L. Fibreoptic assessment of laryngeal positioning of the paediatric supraglottic airway device I-Gel. Eur J Anaesthesiol. 2013 Jul;30(7):441-2. doi: 10.1097/EJA.0b013e32835f9969. No abstract available.

    PubMed 23571478
  • Hughes C, Place K, Berg S, Mason D. A clinical evaluation of the I-gel supraglottic airway device in children. Paediatr Anaesth. 2012 Aug;22(8):765-71. doi: 10.1111/j.1460-9592.2012.03893.x. Epub 2012 Jun 1.

    PubMed 22672411
  • Jagannathan N, Sommers K, Sohn LE, Sawardekar A, Shah RD, Mukherji II, Miller S, Voronov P, Seraphin S. A randomized equivalence trial comparing the i-gel and laryngeal mask airway Supreme in children. Paediatr Anaesth. 2013 Feb;23(2):127-33. doi: 10.1111/pan.12078. Epub 2012 Nov 27.

    PubMed 23189931
  • Emmerich M, Tiesmeier J. The I-gel supraglottic airway: a useful tool in case of difficult fiberoptic intubation. Minerva Anestesiol. 2012 Oct;78(10):1169-70. No abstract available.

    PubMed 23059523
  • Kim YL, Seo DM, Shim KS, Kim EJ, Lee JH, Lee SG, Ban JS. Successful tracheal intubation using fiberoptic bronchoscope via an I-gel supraglottic airway in a pediatric patient with Goldenhar syndrome -A case report-. Korean J Anesthesiol. 2013 Jul;65(1):61-5. doi: 10.4097/kjae.2013.65.1.61. Epub 2013 Jul 19.

    PubMed 23904941
  • Kim MS, Oh JT, Min JY, Lee KH, Lee JR. A randomised comparison of the i-gel and the Laryngeal Mask Airway Classic in infants. Anaesthesia. 2014 Apr;69(4):362-7. doi: 10.1111/anae.12592.

    PubMed 24641642
  • Jagannathan N, Sohn LE, Sawardekar A, Gordon J, Shah RD, Mukherji II, Roth AG, Suresh S. A randomized trial comparing the Ambu (R) Aura-i with the air-Q intubating laryngeal airway as conduits for tracheal intubation in children. Paediatr Anaesth. 2012 Dec;22(12):1197-204. doi: 10.1111/pan.12024. Epub 2012 Sep 13.

    PubMed 22971118
  • Park C, Bahk JH, Ahn WS, Do SH, Lee KH. The laryngeal mask airway in infants and children. Can J Anaesth. 2001 Apr;48(4):413-7. doi: 10.1007/BF03014975.

    PubMed 11339788
  • Jagannathan N, Sohn L, Ramsey M, Huang A, Sawardekar A, Sequera-Ramos L, Kromrey L, De Oliveira GS. A randomized comparison between the i-gel and the air-Q supraglottic airways when used by anesthesiology trainees as conduits for tracheal intubation in children. Can J Anaesth. 2015 Jun;62(6):587-94. doi: 10.1007/s12630-014-0304-9. Epub 2014 Dec 24.

    PubMed 25537736

Questions about this trial

What is this clinical trial studying?

A study testing i-gel and air-Q in people with Tracheal Intubation in Children, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Successful Tracheal Intubation (time frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02189590, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in